Instituto Nacional de Pediatria

Mexico City, Mexico City 4530

1 studies enrolling now · 5 studies all time

What they study most

Acute Lymphoblastic Leukemia (ALL), COVID-19, Diabetes Mellitus, Type 2, Muscular Atrophy, Spinal

Studies at this site

• EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease — Recruiting now
• A Study to Learn About the Long-Term Safety of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Took Part in an Earlier Nusinersen Trial (ONWARD) — Running, not enrolling
• Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy — Completed
• Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia — Completed
• Phase 3 Alogliptin Pediatric Study — Completed